A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
4d
AZoLifeSciences on MSNScientists Build Live African Swine Fever Virus From Synthetic DNA Using CRISPRCas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for ...
A recent study showcases the power of CRISPR gene editing to significantly boost the production of resveratrol, a ...
5d
MyChesCo on MSNCMTA Invests $300,000 in Groundbreaking Gene Editing Therapy for CMT2AThe Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed ...
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...
Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...
The complexity of the TME in vivo limits the conclusions that can be drawn from in vivo models. Optimizing cell culture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results